Skip to main content

Month: August 2025

Summary Notice of Proposed Settlement of Derivative Actions

OVERLAND PARK, Kan., Aug. 28, 2025 (GLOBE NEWSWIRE) — Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, today released the following notice: A U.S. District Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMPASS MINERALS INTERNATIONAL, INC. (“COMPASS” OR THE “COMPANY”) COMMON STOCK AS OF JULY 14, 2025 (THE “RECORD DATE”). IF YOU WERE A RECORD OR BENEFICIAL OWNER OF THE COMPANY’S COMMON STOCK AS OF THE RECORD DATE, PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY, AS YOUR RIGHTS MAY BE AFFECTED BY PROCEEDINGS IN THE ABOVE-REFERENCED LITIGATION. PLEASE TAKE NOTICE that the above-captioned consolidated derivative actions are being settled on the terms set forth in a Stipulation and Agreement of Settlement dated July...

Continue reading

Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date

Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025 Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025 Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025 Notice of Guaranteed Delivery is Available for Warrant Exercises 12.6 Million Warrants Already Exercised for Approximately $110.1 Million Gross Proceeds FREMONT, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the alternate price condition applicable to the Company warrants currently traded on Nasdaq under ENVXW (the “Warrants”) was satisfied on August 28, 2025 in accordance with the Warrant Agreement, dated as of July 21, 2025, between Enovix and Computershare Trust Company...

Continue reading

Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase

– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $233.1 million through the Medicare Shared Savings Program (MSSP) for the 2024 performance year, a 32% increase from 2023. The nine ACOs (collectively, Privia Quality Network or PQN) managed over $2.5 billion in healthcare benchmark spend through approximately 3,280 providers delivering high-value, cost-efficient care to approximately 194,700 Medicare beneficiaries in 2024. “Our strong performance in the 2024 Medicare Shared Savings Program underscores the effectiveness of our physician-led approach,”...

Continue reading

Acuity to Announce Fiscal 2025 Fourth-Quarter and Full-Year Results on October 1, 2025

ATLANTA, Aug. 28, 2025 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2025 fourth-quarter and full-year results on Wednesday, October 1, 2025 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call. The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company’s website at www.investors.acuityinc.com on Wednesday, October 1, 2025. The online replay will remain available for a limited time following the call. A replay of the call will also be posted to the Investor Relations site two hours after the completion of the conference call and will be archived on the website. To learn more about Acuity, please visit the Company’s website. About Acuity Acuity...

Continue reading

AIP Realty Trust Announces Second Quarter 2025 Results

VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) — AIP Realty Trust (the “Trust” or “AIP Realty”) (TSXV:AIP.U) today announced its financial results for the three and six months ended June 30, 2025. All dollar amounts are stated in U.S. dollars. Q2 2025 HighlightsInvestment property revenue for the three ended June 30, 2025 was $150,403, compared to $152,591 in the same period in 2024, a decrease of $2,188, or 1%. The decline in investment property revenue was mainly due to a decline in parking revenue from a 2024 lease expiration that included a large parking agreement component and normal turnover that resulted in the vacancy of one unit starting in mid April 2025, partially offset by increased other revenue generated by tenant move-out charges. Investment property operating expense for the three months ended June...

Continue reading

ParaZero Announces First Half of 2025 Financial Results

Sales increased by approximately 27% compared to the same period in 2024 KFAR SABA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, reported today its financial results for the six months ended June 30, 2025. Key Highlights of ParaZero’s Achievements in the First Half of 2025 & Recent Updates: Financial and Corporate Updates:Sales increased by 26.6% to $357,979 for the six months ended June 30, 2025. ParaZero raised approximately $3.1 million and $2.2 million in gross proceeds from registered direct offerings in February 2025 and August 2025, respectively Appointed Ariel Alon, a senior UAV executive, as company’s CEO.Counter-Drone...

Continue reading

Ambarella, Inc. Announces Second Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced financial results for its second quarter of fiscal year 2026 ended July 31, 2025.Revenue for the second quarter of fiscal 2026 was $95.5 million, up 49.9% from $63.7 million in the same period in fiscal 2025. For the six months ended July 31, 2025, revenue was $181.4 million, up 53.5% from $118.2 million for the six months ended July 31, 2024. Gross margin under U.S. generally accepted accounting principles (GAAP) for the second quarter of fiscal 2026 was 58.9%, compared with 60.8% for the same period in fiscal 2025. For the six months ended July 31, 2025, GAAP gross margin was 59.4%, compared with 60.8% for the six months ended July 31, 2024. GAAP net loss for the second quarter of fiscal 2026...

Continue reading

IREN Reports Full Year FY25 Results

Record Earnings and Profitability Expansion to 10.9k GPUs & $200-250m AI Cloud Annualized Revenue by Dec 20251 GPU Financing & NVIDIA Preferred Partner Status Secured New Liquid-Cooled GB300 NVL72 Deployments NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN” or “the Company”) today reported its financial results for the full fiscal year ended June 30, 2025. HighlightsQ4 FY25 revenue of $187.3m, net income of $176.9m, Adj. EBITDA of $121.9m2, and EBITDA of $241.4m2 Approaching $1.25bn total annualized revenue with scope for further growth ahead3>$1bn annualized revenue from Bitcoin mining under current mining economics4 $200-250m annualized revenue from AI Cloud at 10.9k NVIDIA GPUs by Dec 20251Capacity to deploy >60,000 NVIDIA Blackwell GPUs across existing British Columbia data centers,...

Continue reading

Carlsmed® Reports Second Quarter 2025 Financial Results

Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M – $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) — Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the second quarter ended June 30, 2025. “Our strong commercial performance was driven by the continued adoption of our highly differentiated AI-enabled aprevo® technology platform and growing recognition of its ability to deliver more favorable patient outcomes than legacy devices,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “Building upon our momentum in personalized lumbar fusion surgery, in July we successfully completed the first personalized cervical spine surgery using our aprevo® technology...

Continue reading

Toll Brothers Announces Model Home Grand Opening at Jason’s Walk in Cumming, Georgia

Contemporary model home showcases the luxury homes available in this exclusive community with access to top-rated Forsyth County Schools CUMMING, Ga., Aug. 28, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, today announced the highly anticipated grand opening of the model home at its Jason’s Walk community in Cumming, Georgia. The Rosalynn Contemporary model home is now open at 3445 Austin Michael Lane in Cumming. “The Rosalynn Contemporary model home at Jason’s Walk showcases the exceptional luxury design and craftsmanship for which Toll Brothers is known and provides home shoppers with a glimpse of the high-quality finishes and innovative architectural details available in this exclusive community,” said Eric White, Division President of Toll Brothers in Georgia....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.